IE
CLOV icon

Israel Englander’s Clover Health Investments CLOV Stock Holding History

Israel Englander’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.81M Sell
1,108,721
-56,247
-5% -$191K ﹤0.01% 2843
2026
Q1 		$2.05M Buy
+1,164,968
New +$2.53M ﹤0.01% 3852
2025
Q4 		– Sell
-231,166
Closed -$707K – 6060
2025
Q3 		$707K Sell
231,166
-827,049
-78% -$2.36M ﹤0.01% 4863
2025
Q2 		$2.95M Sell
1,058,215
-4,745,791
-82% -$15.6M ﹤0.01% 3518
2025
Q1 		$20.8M Buy
5,804,006
+4,558,305
+366% +$18.3M 0.01% 1465
2024
Q4 		$3.92M Buy
1,245,701
+1,221,612
+5,071% +$4.37M ﹤0.01% 3044
2024
Q3 		$67.9K Sell
24,089
-180,681
-88% -$414K ﹤0.01% 5653
2024
Q2 		$252K Sell
204,770
-609,018
-75% -$547K ﹤0.01% 5015
2024
Q1 		$646K Sell
813,788
-717,115
-47% -$653K ﹤0.01% 4634
2023
Q4 		$1.46M Sell
1,530,903
-2,493,765
-62% -$2.45M ﹤0.01% 3856
2023
Q3 		$4.35M Sell
4,024,668
-626,250
-13% -$745K ﹤0.01% 2826
2023
Q2 		$4.17M Buy
4,650,918
+4,631,050
+23,309% +$4.11M ﹤0.01% 2826
2023
Q1 		$17K Sell
19,868
-931,582
-98% -$1.02M ﹤0.01% 5905
2022
Q4 		$884K Buy
951,450
+872,778
+1,109% +$1.16M ﹤0.01% 4282
2022
Q3 		$134K Buy
+78,672
New +$206K ﹤0.01% 5853
2022
Q2 		– Sell
-854,198
Closed -$2.27M – 7027
2022
Q1 		$3.03M Sell
854,198
-883,168
-51% -$2.56M ﹤0.01% 3487
2021
Q4 		$6.46M Buy
1,737,366
+1,139,777
+191% +$6.99M ﹤0.01% 2634
2021
Q3 		$4.42M Sell
597,589
-410,142
-41% -$3.51M ﹤0.01% 3007
2021
Q2 		$13.4M Buy
1,007,731
+382,033
+61% +$3.75M 0.01% 1563
2021
Q1 		$4.73M Buy
+625,698
New +$7.06M ﹤0.01% 2628
2020
Q4 		– Sell
-3,294,079
Closed -$36.7M – 5230
2020
Q3 		$41K Buy
3,294,079
+794,080
+32% +$8.79M 0.05% 406
2020
Q2 		$27.9M Buy
+2,499,999
New +$26.9M 0.04% 551

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Israel Englander's CLOV Position: Q2 2026 in Review

Israel Englander reduced its Clover Health Investments (CLOV) stake by 4.8% in Q2 2026, selling an estimated $191K and leaving 1,108,721 shares worth $5.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Israel Englander first reported a position in CLOV in Q2 2020 and has held it in 22 quarters since. The position peaked at $27.9M in Q2 2020. 224 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Israel Englander held 1,108,721 shares of Clover Health Investments worth $5.81M as of Q2 2026.
  • Israel Englander sold 56,247 Clover Health Investments shares in Q2 2026, an estimated $191K.
  • Clover Health Investments made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2843 holding.
  • Israel Englander first reported a position in Clover Health Investments in Q2 2020 and has held it in 22 quarters since.
  • Israel Englander's Clover Health Investments position peaked at $27.9M in Q2 2020.
  • 224 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.